Copyright
©The Author(s) 2025.
World J Diabetes. Jun 15, 2025; 16(6): 105447
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.105447
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.105447
Table 4 Generalized estimating equations multiple regression analysis for triglyceride
Variables (n = 224) | Categories | Crude effect | Adjusted effect | ||
β (95%CI) | P value | β (95%CI) | P value | ||
Vaccination status | Vaccinated | 0.07 (-2.76, 2.91) | 0.9591 | 1.46 (-1.09, 4.02) | 0.263 |
Unvaccinated | Reference | Reference | |||
Time | < 0.00a | < 0.00b | |||
3 months | 0.15 (-3.40, 3.71) | 0.933 | 0.15 (-3.40, 3.71) | 0.933 | |
6 months | 0.35 (-3.62, 4.32) | 0.862 | 0.35 (-3.62, 4.32) | 0.862 | |
9 months | -0.67 (-2.84, 1.49) | 0.542 | -0.67 (-2.84, 1.49) | 0.542 | |
1 year | 0.07 (-2.09, 2.24) | 0.948 | 0.07 (-2.09, 2.24) | 0.948 | |
Base line | Reference | Reference | |||
Group timeb | 0.070 | ||||
Vaccinated 3 months | 3.87 (-2.99, 10.72) | 0.269 | |||
Vaccinated 6 months | 1.90 (-5.29, 9.10) | 0.604 | |||
Vaccinated 9 months | -0.77 (-6.49, 4.96) | 0.793 | |||
Vaccinated 1 year | -1.77 (-7.49, 3.96) | 0.546 | |||
Vaccinated baseline | Reference | ||||
Age group | ≤ 40 years | -12.92 (-16.27, -9.57) | < 0.001a | -13.29 (-16.70, -9.88) | < 0.001b |
> 40 years | Reference | Reference | |||
Sex | Female | -6.40 (-10.33, -2.48) | 0.001a | -8.68 (-12.41, -4.95) | < 0.001b |
Male | Reference | Reference | |||
Alcohol exposure | Yes | -6.38 (-10.42, -2.35) | 0.002a | -8.77 (-12.64, -4.89) | < 0.001b |
No | Reference | Reference | |||
Chat exposure | Yes | 2.45 (-3.18, 8.09) | 0.394 | ||
No | Reference | ||||
Smoking exposure | Yes | 3.32 (-7.28, 13.93) | 0.539 | ||
No | Reference | ||||
Medications | 0.003a | 0.394 | |||
Insulin | 1.16 (-4.15, 6.47) | 0.668 | 0.79 (-3.97, 5.56) | 0.745 | |
Metformin | 7.08 (2.73, 11.44) | 0.001 | 2.75 (-1.23, 6.72) | 0.176 | |
Both | Reference | Reference | |||
Intercept | 167.68 |
- Citation: Edae CK, Bedada AT, Teklemariam MD, Girma T, Gebre SG. Longitudinal effects of Johnson & Johnson COVID-19 vaccination on metabolic biomarkers in type 2 diabetes mellitus in Ethiopia. World J Diabetes 2025; 16(6): 105447
- URL: https://www.wjgnet.com/1948-9358/full/v16/i6/105447.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i6.105447